Can polygenic risk scores help explain disease prevalence differences around the world? A worldwide investigation
Abstract Complex disorders are caused by a combination of genetic, environmental and lifestyle factors, and their prevalence can vary greatly across different populations. The extent to which genetic risk, as identified by Genome Wide Association Study (GWAS), correlates to disease prevalence in different populations has not been investigated systematically. Here, we studied 14 different complex disorders and explored whether polygenic risk scores (PRS) based on current GWAS correlate to disease prevalence within Europe and around the world. A clear variation in GWAS-based genetic risk was observed based on ancestry and we identified populations that have a higher genetic liability for developing certain disorders. We found that for four out of the 14 studied disorders, PRS significantly correlates to disease prevalence within Europe. We also found significant correlations between worldwide disease prevalence and PRS for eight of the studied disorders with Multiple Sclerosis genetic risk having the highest correlation to disease prevalence. Based on current GWAS results, the across population differences in genetic risk for certain disorders can potentially be used to understand differences in disease prevalence and identify populations with the highest genetic liability. The study highlights both the limitations of PRS based on current GWAS but also the fact that in some cases, PRS may already have high predictive power. This could be due to the genetic architecture of specific disorders or increased GWAS power in some cases..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
BMC genetics - 24(2023), 1 vom: 20. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jain, Pritesh R. [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1186/s12863-023-01168-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR053801695 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR053801695 | ||
| 003 | DE-627 | ||
| 005 | 20231121064818.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231121s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12863-023-01168-9 |2 doi | |
| 035 | |a (DE-627)SPR053801695 | ||
| 035 | |a (SPR)s12863-023-01168-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jain, Pritesh R. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Can polygenic risk scores help explain disease prevalence differences around the world? A worldwide investigation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Abstract Complex disorders are caused by a combination of genetic, environmental and lifestyle factors, and their prevalence can vary greatly across different populations. The extent to which genetic risk, as identified by Genome Wide Association Study (GWAS), correlates to disease prevalence in different populations has not been investigated systematically. Here, we studied 14 different complex disorders and explored whether polygenic risk scores (PRS) based on current GWAS correlate to disease prevalence within Europe and around the world. A clear variation in GWAS-based genetic risk was observed based on ancestry and we identified populations that have a higher genetic liability for developing certain disorders. We found that for four out of the 14 studied disorders, PRS significantly correlates to disease prevalence within Europe. We also found significant correlations between worldwide disease prevalence and PRS for eight of the studied disorders with Multiple Sclerosis genetic risk having the highest correlation to disease prevalence. Based on current GWAS results, the across population differences in genetic risk for certain disorders can potentially be used to understand differences in disease prevalence and identify populations with the highest genetic liability. The study highlights both the limitations of PRS based on current GWAS but also the fact that in some cases, PRS may already have high predictive power. This could be due to the genetic architecture of specific disorders or increased GWAS power in some cases. | ||
| 650 | 4 | |a GWAS |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a PRS |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Polygenic risk score |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Ancestry |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Disease prevalence |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Burch, Myson |4 aut | |
| 700 | 1 | |a Martinez, Melanie |4 aut | |
| 700 | 1 | |a Mir, Pablo |4 aut | |
| 700 | 1 | |a Fichna, Jakub P. |4 aut | |
| 700 | 1 | |a Zekanowski, Cezary |4 aut | |
| 700 | 1 | |a Rizzo, Renata |4 aut | |
| 700 | 1 | |a Tümer, Zeynep |4 aut | |
| 700 | 1 | |a Barta, Csaba |4 aut | |
| 700 | 1 | |a Yannaki, Evangelia |4 aut | |
| 700 | 1 | |a Stamatoyannopoulos, John |4 aut | |
| 700 | 1 | |a Drineas, Petros |4 aut | |
| 700 | 1 | |a Paschou, Peristera |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC genetics |d London : BioMed Central, 2000 |g 24(2023), 1 vom: 20. Nov. |w (DE-627)SPR02699738X |w (DE-600)2041497-3 |x 1471-2156 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:1 |g day:20 |g month:11 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12863-023-01168-9 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 1 |b 20 |c 11 | ||